Daiichi Sankyo Co Ltd (OTCPK:DSKYF)
$ 29.3 -1.8 (-5.79%) Market Cap: 57.36 Bil Enterprise Value: 50.88 Bil PE Ratio: 33.41 PB Ratio: 5.36 GF Score: 93/100

Daiichi Sankyo Co Ltd ASCO 2022 Highlights Transcript

Jun 07, 2022 / 10:30PM GMT
Release Date Price: $25.45 (-2.97%)
Unidentified Company Representative

[Interpreted] Thank you very much for waiting. Now we'd like to start Daiichi Sankyo's ASCO highlights. I'm Astakura from Corporate Communications Department, and I will serve as MC today.

First, let me explain the language for this meeting. We are going to use Japanese and English in this web conference. Simultaneous interpretation is available. Please click interpretation icon at the bottom of the Zoom screen and select the language from Japanese, English or off. If you select off, you will hear the original sound. English presentation materials will be displayed on the Zoom screen. Presentation materials in Japanese and English are posted on our corporate website under the IR Materials section in the IR library. You can download the file for your reference, if you want.

Today, 3 members are participating as shown on Page 3. President and CEO, Sunao Manabe; Head of Global R&D, Ken Takeshita; and Head of Global Oncology Clinical Development, Gilles Gallant. You can find the agenda for today on Page 4. First, Ken Takeshita will make an introduction, and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot